Published in
American Association for the Advancement of Science, Science Translational Medicine, 612(13), 2021
DOI: 10.1126/scitranslmed.abh2624
Links
Tools
Type I interferon autoantibodies are associated with systemic immune alterations in patients with COVID-19
Journal article published in 2021 by
Monique G. P. van der Wijst 
,
Sara E. Vazquez,
George C. Hartoularos,
on behalf of the U. C. S. F. C. O. M. E. T. Consortium,
Paul Bastard,
Deanna S. Lee,
Tianna Grant,
Yumiko Abe-Jones,
Raymund Bueno ,
Bonny Alvarenga,
David S. Lee ,
Saurabh Asthana,
John R. Greenland,
Alexander Beagle,
Yang Sun
and other authors.
,
Sara E. Vazquez,
George C. Hartoularos,
on behalf of the U. C. S. F. C. O. M. E. T. Consortium,
Paul Bastard,
Deanna S. Lee,
Tianna Grant,
Yumiko Abe-Jones,
Raymund Bueno ,
Bonny Alvarenga,
David S. Lee ,
Saurabh Asthana,
John R. Greenland,
Alexander Beagle,
Yang Sun
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 
Abstract
Type I interferon autoantibodies in patients with COVID-19 are associated with poor interferon responses and increased LAIR1 abundance in leukocytes.